MOHAN PANKAJ (Chairman, President and CEO) purchased 49.3% of their position (60K shares) of SONNET BIOTHERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $35.1K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 3/16/2023ACC: 0001493152-23-007915
DirectorOfficer· Chairman, President and CEO
Since Apr 2020
+60K
Net shares
Net buyer
$35.1K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
60K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+60K
Price / share
$0.58
Trade value
$35.10K
% of position
49.3%
3/15/2023
121.73K→181.73K
Total
Net shares
+60K
Net value
$35.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/15/2023 | P · Purchase | +60K | $0.58 | $35.10K | 49.3% | 121.73K | 181.73K |
| Total | +60K | $35.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned66.48K
Common Stock
IndirectShares owned570.00
Total
67.05K indirect67.05K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 66.48K | Indirect |
| Common Stock | 570.00 | Indirect |
| Total | 67.05K | 67.05K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported